Literature DB >> 30002140

Adapting and Evaluating a Health System Intervention From Kaiser Permanente to Improve Hypertension Management and Control in a Large Network of Safety-Net Clinics.

Valy Fontil1,2, Reena Gupta3, Nathalie Moise4, Ellen Chen5, David Guzman3,2, Charles E McCulloch, Kirsten Bibbins-Domingo3,6,2.   

Abstract

BACKGROUND: Nearly half of Americans with diagnosed hypertension have uncontrolled blood pressure (BP) while some integrated healthcare systems, such as Kaiser Permanente Northern California, have achieved control rates upwards 90%. METHODS AND
RESULTS: We adapted Kaiser Permanente's evidence-based treatment protocols in a racially and ethnically diverse population at 12 safety-net clinics in the San Francisco Health Network. The intervention consisted of 4 elements: a hypertension registry, a simplified treatment intensification protocol that included fixed-dose combination medications containing diuretics, standardized BP measurement protocol, and BP check visits led by registered nurse and pharmacist staff. The study population comprised patients with hypertension who made ≥1 primary care visits within the past 24 months (n=15 917) and had a recorded BP measurement within the past 12 months. We conducted a postintervention time series analysis from August 2014 to August 2016 to assess the effect of the intervention on BP control for 24 months for the pilot site and for 15 months for 11 other San Francisco Health Network clinics combined. Secondary outcomes were changes in use of guideline-recommended medication prescribing. Rates of BP control increased at the pilot site (68%-74%; P<0.01) and the 11 other San Francisco Health Network clinic sites (69%-74%; P<0.01). Statistically significant improvements in BP control rates (P<0.01) at the 11 San Francisco Health Network clinic sites occurred in all racial and ethnic groups (blacks, 60%-66%; whites, 69%-75%; Latinos, 67%-72%; Asians, 78%-82%). Use of fixed-dose combination medications increased from 10% to 13% (P<0.01), and the percentage of angiotensin-converting enzyme inhibitor prescriptions dispensed in combination with a thiazide diuretic increased from 36% to 40% (P<0.01).
CONCLUSIONS: Evidence-based system approaches to improving BP control can be implemented in safety-net settings and could play a pivotal role in achieving improved population BP control and reducing hypertension disparities.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; ethnic; hypertension; safety-net providers

Mesh:

Substances:

Year:  2018        PMID: 30002140      PMCID: PMC6071320          DOI: 10.1161/CIRCOUTCOMES.117.004386

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  16 in total

1.  Fixed-dose combinations improve medication compliance: a meta-analysis.

Authors:  Sripal Bangalore; Gayathri Kamalakkannan; Sanobar Parkar; Franz H Messerli
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

2.  Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy.

Authors:  Song Hee Hong; Junling Wang; Jun Tang
Journal:  Am J Hypertens       Date:  2013-03-18       Impact factor: 2.689

3.  Cost-effectiveness of hypertension therapy according to 2014 guidelines.

Authors:  Andrew E Moran; Michelle C Odden; Anusorn Thanataveerat; Keane Y Tzong; Petra W Rasmussen; David Guzman; Lawrence Williams; Kirsten Bibbins-Domingo; Pamela G Coxson; Lee Goldman
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

4.  Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.

Authors:  Valy Fontil; Kirsten Bibbins-Domingo; Dhruv S Kazi; Stephen Sidney; Pamela G Coxson; Raman Khanna; Ronald G Victor; Mark J Pletcher
Journal:  J Gen Intern Med       Date:  2015-03-07       Impact factor: 5.128

5.  Race-ethnicity on blood pressure control after ischemic stroke: a prospective cohort study.

Authors:  Mai N Nguyen-Huynh; Nancy K Hills; Stephen Sidney; Jeffrey G Klingman; S Claiborne Johnston
Journal:  J Am Soc Hypertens       Date:  2016-11-17

Review 6.  Interventions used to improve control of blood pressure in patients with hypertension.

Authors:  Liam G Glynn; Andrew W Murphy; Susan M Smith; Knut Schroeder; Tom Fahey
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

7.  A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.

Authors:  Ross D Feldman; Guang Y Zou; Margaret K Vandervoort; Cindy J Wong; Sigrid A E Nelson; Brian G Feagan
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

8.  Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy?

Authors:  Michael Mueller; Tanjala S Purnell; George A Mensah; Lisa A Cooper
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

9.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

Review 10.  Angiotensin-converting enzyme inhibitors.

Authors:  Joseph L Izzo; Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

View more
  14 in total

1.  Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.

Authors:  Paul Muntner; Shakia T Hardy; Lawrence J Fine; Byron C Jaeger; Gregory Wozniak; Emily B Levitan; Lisandro D Colantonio
Journal:  JAMA       Date:  2020-09-22       Impact factor: 56.272

2.  Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals.

Authors:  Brandon K Bellows; Natalia Ruiz-Negrón; Kirsten Bibbins-Domingo; Jordan B King; Mark J Pletcher; Andrew E Moran; Valy Fontil
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-06-05

3.  The Relationship Between Racial/Ethnic Concordance and Hypertension Control.

Authors:  Francesca Adriano; Raoul J Burchette; Alyson C Ma; Alison Sanchez; Mindy Ma
Journal:  Perm J       Date:  2021-08-06

Review 4.  Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension.

Authors:  Gabriel S Tajeu; Stavros Tsipas; Michael Rakotz; Gregory Wozniak
Journal:  Am J Hypertens       Date:  2022-03-08       Impact factor: 3.080

5.  Improved hypertension control at six months using an adapted WHO HEARTS-based implementation strategy at a large urban HIV clinic in Uganda.

Authors:  Martin Muddu; Fred C Semitala; Isaac Kimera; Mary Mbuliro; Rebecca Ssennyonjo; Simon P Kigozi; Rodgers Katwesigye; Florence Ayebare; Christabellah Namugenyi; Frank Mugabe; Gerald Mutungi; Chris T Longenecker; Anne R Katahoire; Isaac Ssinabulya; Jeremy I Schwartz
Journal:  BMC Health Serv Res       Date:  2022-05-25       Impact factor: 2.908

6.  Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control.

Authors:  Valy Fontil; Lucia Pacca; Brandon K Bellows; Elaine Khoong; Charles E McCulloch; Mark Pletcher; Kirsten Bibbins-Domingo
Journal:  JAMA Cardiol       Date:  2022-02-01       Impact factor: 30.154

7.  Reducing Cardiovascular Risk for Patients With Diabetes: An Evidence-Based, Population Health Management Program.

Authors:  Carly Levitz; Maggie Jones; Jean Nudelman; Michael Cox; Diana Camacho; Alexis Wielunski; Michael Rothman; Juliane Tomlin; Marc Jaffe
Journal:  J Healthc Qual       Date:  2022 Mar-Apr 01       Impact factor: 1.028

8.  County-Level Trends in Hypertension-Related Cardiovascular Disease Mortality-United States, 2000 to 2019.

Authors:  Adam S Vaughan; Fátima Coronado; Michele Casper; Fleetwood Loustalot; Janet S Wright
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

9.  Refocusing on hypertension control in Canada.

Authors:  Alexander A Leung; Alan Bell; Ross T Tsuyuki; Norman R C Campbell
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

10. 

Authors:  Alexander A Leung; Alan Bell; Ross T Tsuyuki; Norman R C Campbell
Journal:  CMAJ       Date:  2021-08-23       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.